1.5 mg retatrutide Retratrutide "Peptide" 1 x 5mg vial Retatrutide, an experimental weight-loss drug,

Although classified as a sugar, the body handles it differently it does not raise blood glucose and provides significantly fewer calories (about 0.4 kcal/g versus 4 kcal/g for traditional sugar)

In the STEP 1 trial, dual-energy X-ray absorptiometry (DXA) substudies showed that semaglutide treatment resulted in a greater proportional decrease in fat mass compared to lean body mass over 68 weeks, though absolute lean mass reductions were observed alongside the predominant fat loss

While semaglutide does not require dose adjustment for kidney impairment, your provider should assess your overall health status, including kidney function

[PubMed: 10569655] 828